Notably, patients treated with a combination of anti-CTLA-4 and anti-PD-1 drugs who developed ICI-induced colitis overexpressed mucosal IL-1β (as well as IL-17), but not TNF-α, with a higher abundance of Bacteroides intestinalis [109]. Here, PDCD1 is linked to colitis.